Respiratory tuberculosis, confirmed

AB1_RESP_TUBERCU_CONF

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 A15
  • Hospital discharge: ICD-9 01[1-2].A
  • Cause of death: ICD-10 A15
  • Cause of death: ICD-9 01[1-2].A

2 out of 7 registries used, show all original rules.

728

4. Check minimum number of events

None

728

5. Include endpoints

None

728

6. Filter based on genotype QC (FinnGen only)

728

Control definitions (FinnGen only)

Control exclude
AB1_TUBERCULOSIS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 10043 3678 6041
Only index persons 5568 2240 3328
Unadjusted period prevalence (%)
Whole population 0.15 0.11 0.17
Only index persons 0.11 0.08 0.13
Median age at first event (years)
Whole population 65.07 68.60 63.07
Only index persons 58.70 59.64 58.07

-FinnGen-

Key figures

All Female Male
Number of individuals 728 236 492
Unadjusted period prevalence (%) 0.17 0.08 0.22
Median age at first event (years) 62.16 54.36 65.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
681
Matched controls
6811
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
+∞
313.5
276
*
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
+∞
218.9
198
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.5
85.4
232
440
0110A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, BAKTER.VARMA]
+∞
78.7
74
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.6
74.6
195
341
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
66.5
67.2
77
13
A15.2
ICD-10 Finland
Tuberculosis of lung, confirmed histologically
+∞
64.6
61
*
A70
ICPC
Tuberculosis
630.3
59.6
58
*
A15.6
ICD-10 Finland
Tuberculous pleurisy, confirmed bacteriologically and histologically
+∞
50.6
48
*
A15.9
ICD-10 Finland
Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
478.1
45.8
45
*
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
65.4
37.6
43
7
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
+∞
34.7
33
*
A15.3
ICD-10 Finland
Tuberculosis of lung, confirmed by unspecified means
+∞
34.7
33
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
32.7
310
1582
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.4
31.9
182
659
A15.7
ICD-10 Finland
Primary respiratory tuberculosis, confirmed bacteriologically and histologically
+∞
30.4
29
*
0112A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung with cavitation[TUBERCULOSIS PULMONUM CAVERNOSA, BAKTERIOL.VARMA]
+∞
28.3
27
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.3
26.2
84
176
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
26.2
144
500
R03BB04
ATC
tiotropium bromide; inhalant
3.2
24.0
141
511
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.4
21.8
68
138
A15.8
ICD-10 Finland
Other respiratory tuberculosis, confirmed bacteriologically and histologically
+∞
20.9
20
*
1240
FHL
Bronchoscopy
9.0
18.9
40
47
A16.2
ICD-10 Finland
Tuberculosis of lung, without mention of bacteriological or histological confirmation
+∞
18.8
18
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.8
18.7
82
234
Z03.0
ICD-10 Finland
Observation for suspected tuberculosis
39.6
18.6
23
6
A15.4
ICD-10 Finland
Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically
+∞
17.8
17
*
H02AB06
ATC
prednisolone; systemic
2.0
17.7
339
2222
J01MA14
ATC
moxifloxacin; systemic
3.2
17.4
98
341
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.5
16.8
61
146
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
16.3
312
2024
R04.2
ICD-10 Finland
Haemoptysis
4.7
16.3
56
127
J96.1
ICD-10 Finland
Chronic respiratory failure
5.6
15.1
44
83
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.3
14.7
45
90
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.2
14.2
54
136
TGC00
NOMESCO Finland
Bronchial lavation
5.5
14.0
41
78
J47
ICD-10 Finland
Bronchiectasis
7.6
13.9
32
44
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.2
13.6
166
883
0119A
ICD-9 Finland
Pulmonary tuberculosis, unspecified[TUBERCULOSIS PULMONUM NUD, BAKTERIOLOG. VARMA]
+∞
13.6
13
*
R03DA04
ATC
theophylline; systemic, rectal
2.9
13.6
89
339
R03AC02
ATC
salbutamol; inhalant
1.9
13.5
323
2218
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
9.3
12.8
26
29
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
12.8
66
215
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
12.3
54
155
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.0
11.5
69
248
R03BB01
ATC
ipratropium bromide; inhalant
2.9
11.3
69
251
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
11.2
133
693
H02AB07
ATC
prednisone; oral
2.2
11.0
125
637
J01FA06
ATC
roxithromycin; oral
1.8
11.0
264
1783
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
10.9
291
2027
R03AC12
ATC
salmeterol; inhalant
3.0
10.7
61
214
0310A
ICD-9 Finland
Diseases due to other mycobacteria, Pulmonary
+∞
10.4
10
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.7
10.3
45
129
1370A
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,TUBERKULOOSIARPI]
40.7
10.0
12
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
9.8
141
790
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
9.5
121
646
GD1AD
NOMESCO Finland
Thorax CT examination
3.3
9.0
44
139
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
8.9
122
671
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.0
8.8
27
56
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.9
8.7
52
189
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
8.6
113
610
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.6
175
1104
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.3
8.6
83
393
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.2
8.4
42
135
A16.5
ICD-10 Finland
Tuberculous pleurisy, without mention of bacteriological or histological confirmation
+∞
8.3
8
*
0119X
ICD-9 Finland
Pulmonary tuberculosis, unspecified[TUBERCULOSIS PULMONUM NUD, EPÄILTY]
+∞
8.3
8
*
A16.1
ICD-10 Finland
Tuberculosis of lung, bacteriological and histological examination not done
+∞
8.3
8
*
A31.9
ICD-10 Finland
Mycobacterial infection, unspecified
+∞
8.3
8
*
0110X
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, EPÄILTY]
+∞
8.3
8
*
B90.0
ICD-10 Finland
Sequelae of central nervous system tuberculosis
+∞
8.3
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
8.2
139
822
R05
ICD-10 Finland
Cough
1.9
8.1
120
679
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.9
8.1
19
28
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
5.3
7.9
23
45
P15
ICPC
Chronic alcohol abuse
6.2
7.9
20
33
J01MA12
ATC
levofloxacin; systemic
1.8
7.8
147
904
Z20.1
ICD-10 Finland
Contact with and exposure to tuberculosis
18.6
7.6
11
6
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
4.1
7.5
28
71
SPAT1254
SPAT
Administration of medicine
1.9
7.4
111
630
A18.2
ICD-10 Finland
Tuberculous peripheral lymphadenopathy
+∞
7.3
7
*
A18.1
ICD-10 Finland
Tuberculosis of genitourinary system
+∞
7.3
7
*
A16.9
ICD-10 Finland
Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation
+∞
7.3
7
*
0120A
ICD-9 Finland
Other respiratory tuberculosis, Tuberculous pleurisy[TUBERCULOSIS PLEURAE, BAKTERIOLOGISESTI VARMA]
+∞
7.3
7
*
R03BA01
ATC
beclometasone; inhalant
2.0
7.0
95
517
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.8
188
1289
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.2
6.6
23
56
A31.89
ICD-10 Finland
Other mycobacterial infections
70.5
6.4
7
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
6.4
71
359
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.3
6.4
18
35
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
9.4
6.3
12
13
0116A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculous pneumonia [any form][TUBERCULOSIS PULMONUM CUM PNEUMONIA,BAKTER.VARMA]
+∞
6.3
6
*
A18.3
ICD-10 Finland
Tuberculosis of intestines, peritoneum and mesenteric glands
+∞
6.3
6
*
0118A
ICD-9 Finland
Pulmonary tuberculosis, Other specified pulmonary tuberculosis[TUBERCULOSIS PULMONUM ALIA, BAKTERIOLOG.VARMA]
+∞
6.3
6
*
A18.0
ICD-10 Finland
Tuberculosis of bones and joints
+∞
6.3
6
*
A15
ICD-10 Finland
Respiratory tuberculosis, bacteriologically and histologically confirmed
+∞
6.3
6
*
A15.5
ICD-10 Finland
Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically
+∞
6.3
6
*
A19.1
ICD-10 Finland
Acute miliary tuberculosis of multiple sites
+∞
6.3
6
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
7.1
6.2
14
20
N05BA02
ATC
chlordiazepoxide; systemic
3.7
6.2
25
69
R99
ICPC
Respiratory disease other
4.7
6.1
19
41
GAC00
NOMESCO Finland
Biopsy of pleura
10.1
6.0
11
11
N05CD07
ATC
temazepam; oral
1.8
6.0
111
672

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
195
194
13.36
181.34
7.2
2.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
103
56
21.26
132.19
13.0
3.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
89
135
7.37
57.33
2.9
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
59
80
7.94
41.70
7.7
2.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
168
611
3.27
36.13
1.8
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
51
79
6.87
31.92
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
10
23.72
31.58
1.7
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
56
129
4.62
22.86
1.8
1.6
iu/ml
1.4
0.1
3.14
19
32
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
24
10.75
22.78
8.4
4.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
94
5.28
22.62
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
77
5.58
21.12
1.6
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
270
1618
2.06
18.50
12.4
5.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
51
130
4.14
18.27
1.8
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
29
48
6.25
16.96
1.4
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
128
586
2.44
16.86
1.9
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
129
3.83
15.21
1.9
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
25
8.20
14.95
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
350
2417
1.86
14.93
11.3
5.3
e9/l
0.0
0.0
0.31
307
2079
(3001604) Monocytes [#/volume] in Blood
348
2404
1.86
14.78
11.3
5.3
e9/l
0.7
0.6
1.87
303
2055
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
36
83
4.51
14.66
1.6
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
33
71
4.82
14.60
3.6
2.9
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
28
52
5.56
14.58
1.4
1.3
u/l
16.0
14.5
0.35
28
47
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
72
4.75
14.36
1.5
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
331
2268
1.84
14.29
11.9
5.5
%
2.8
2.9
0.12
313
2100
(3019069) Monocytes/100 leukocytes in Blood
332
2278
1.84
14.26
12.3
5.9
%
9.1
8.9
0.28
315
2120
(3022096) Basophils/100 leukocytes in Blood
324
2212
1.84
14.10
11.8
5.5
%
0.6
0.6
0.25
307
2051
(3013115) Eosinophils [#/volume] in Blood
355
2495
1.83
14.02
12.1
5.6
e9/l
0.2
0.2
0.15
314
2180
(3012095) Magnesium [Moles/volume] in Serum or Plasma
153
825
2.08
13.36
4.8
3.3
mmol/l
0.8
0.8
1.17
147
764
(4015189)
15
15
10.19
13.16
2.6
2.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
329
2291
1.80
13.14
11.5
5.5
%
58.1
58.5
0.22
311
2136
(3019198) Lymphocytes [#/volume] in Blood
348
2465
1.79
13.11
11.5
5.5
e9/l
2.2
1.8
0.54
308
2171
(3002030) Lymphocytes/100 leukocytes in Blood
333
2330
1.79
13.06
12.0
5.7
%
26.3
26.1
0.09
312
2157
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
371
2696
1.77
12.64
11.0
6.2
umol/l
9.9
12.1
4.65
362
2544
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
23
42
5.62
12.18
1.3
1.2
iu/ml
1.7
—
—
7
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
48
157
3.20
11.92
1.7
1.6
—
212.5
—
0
8
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
51
5.04
11.76
1.9
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
26
56
4.78
11.49
1.8
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
99
3.66
10.87
1.9
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
131
716
2.01
10.87
6.5
5.4
mmol/l
1.1
1.0
0.83
122
644
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
166
988
1.88
10.70
2.5
1.8
—
—
—
0
0
(44806118)
25
56
4.59
10.55
1.7
1.5
—
—
—
0
0
(44790047)
25
56
4.59
10.55
1.7
1.5
—
—
—
0
0
(44790049)
25
56
4.59
10.55
1.7
1.5
—
—
—
0
0
(44790048)
25
56
4.59
10.55
1.7
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
373
2822
1.66
10.13
15.3
8.6
e9/l
4.4
4.3
0.40
333
2461
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
51
190
2.81
10.11
1.7
2.0
u/l
44.0
37.6
1.26
42
164
(3042936) Bacteria identified in Isolate by Culture
137
803
1.87
9.15
2.4
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
240
1654
1.67
9.13
7.1
4.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
102
545
2.01
8.94
1.4
1.3
titre
410.0
456.4
0.17
24
117
(40768806) Pleura Pathology biopsy report
29
87
3.43
8.29
1.4
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
27
5.65
8.05
1.8
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
27
5.65
8.05
1.8
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
27
5.65
8.05
1.8
1.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
14
7.96
8.00
1.5
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
47
4.35
7.98
1.8
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
47
4.35
7.98
1.8
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
47
4.35
7.98
1.8
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
26
76
3.51
7.73
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
40
4.59
7.68
1.6
1.7
e9/l
1.6
1.0
—
6
21
(3004789) Transferrin [Mass/volume] in Serum or Plasma
132
808
1.77
7.57
3.3
2.4
g/l
2.1
2.3
1.37
121
736
(3022948) Iron [Moles/volume] in Serum or Plasma
141
882
1.74
7.50
3.2
2.4
umol/l
10.6
12.3
2.40
132
803
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
22
6.00
7.40
1.9
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
22
6.00
7.40
1.9
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
126
771
1.77
7.22
3.3
2.5
%
20.2
22.3
0.90
104
658
(40758558) Short blood count panel - Blood
180
1214
1.64
7.20
10.1
6.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
116
696
1.79
7.10
2.4
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
23
5.74
7.08
1.9
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
27
5.27
6.99
1.9
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
52
235
2.31
6.97
1.7
1.2
u/ml
125.4
343.2
1.22
46
211
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
72
371
2.04
6.96
2.1
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
85
468
1.92
6.81
1.7
2.6
g/l
66.3
66.1
0.10
72
417
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
309
2385
1.51
6.77
8.4
5.9
mmol/l
1.2
1.2
0.91
283
2128
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
157
2.57
6.71
1.6
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
114
692
1.77
6.69
2.3
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
99
576
1.83
6.69
2.7
4.3
ug/l
23.3
29.6
0.13
81
495
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
79
3.24
6.62
1.8
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
108
648
1.78
6.59
8.8
7.1
kpa
5.1
5.1
0.03
103
614
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
90
513
1.86
6.49
1.8
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
298
2306
1.49
6.34
6.1
4.7
g/l
33.3
34.8
3.88
270
2129
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
32
120
2.74
6.32
1.2
2.0
mg/l
12.1
13.2
0.24
23
106
(3003396) Base excess in Arterial blood by calculation
107
648
1.76
6.32
8.8
7.2
mmol/l
1.2
1.3
0.09
91
493
(3028433) Virus identified in Specimen by Culture
12
22
5.53
6.30
1.2
1.2
—
—
—
0
0
(4010399)
65
335
2.03
6.29
1.3
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
26
5.07
6.24
1.6
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
81
456
1.87
6.07
1.8
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
1570
1.52
5.97
3.7
3.0
u/l
32.8
34.4
0.27
204
1495
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
80
3.07
5.85
1.3
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
60
310
2.02
5.78
3.5
3.1
e9/l
3.6
4.3
0.90
38
226
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
65
3.30
5.76
1.9
1.5
—
—
—
0
0
(4035726)
77
434
1.87
5.75
1.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
36
151
2.46
5.72
1.4
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
24
82
2.99
5.62
1.3
1.2
e6/l
2117.6
1355.8
0.87
16
53
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
325
2602
1.45
5.62
9.1
6.7
mmol/l
1.2
1.2
0.79
285
2155
(3013707) Erythrocyte sedimentation rate by Westergren method
425
3593
1.44
5.38
7.6
3.9
mm/h
18.1
14.1
3.84
400
3237
(3000991) Gas panel - Venous blood
78
451
1.82
5.38
10.8
7.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
287
2267
1.44
5.23
10.5
10.8
inr
1.2
1.3
0.96
63
636
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
197
2.20
5.20
2.2
2.8
u/ml
0.3
0.3
0.03
22
105
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
495
1.76
5.17
2.4
2.1
g/l
0.2
0.2
0.24
78
453
(3020779) Urea [Moles/volume] in Serum or Plasma
83
495
1.76
5.17
7.4
6.9
mmol/l
11.4
11.2
0.10
78
466
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
451
3873
1.43
5.12
14.0
7.5
u/l
80.6
80.6
0.00
433
3589
(3019060) Gas panel - Arterial blood
69
390
1.85
5.12
4.4
5.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
195
1437
1.49
5.07
2.9
2.1
mg/l
3.1
3.1
0.18
166
1213
(3045788) Cell count panel - Pleural fluid
19
62
3.12
4.82
1.3
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
97
616
1.66
4.82
2.2
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
51
266
1.99
4.81
6.1
4.0
mmol/l
24.8
24.1
0.91
45
239
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
9
10
9.09
4.79
1.2
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
52
3.32
4.77
4.3
2.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
84
515
1.71
4.75
10.1
8.1
g/l
120.7
120.5
0.02
79
495
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
33
3.99
4.73
1.5
1.8
e6/l
721.4
737.7
—
7
15
(3021447) Carbon dioxide [Partial pressure] in Venous blood
85
526
1.70
4.65
4.5
3.7
kpa
5.8
5.8
0.18
80
508
(3028308) Erythrocytes [#/volume] in Pleural fluid
21
75
2.85
4.58
1.3
1.2
e6/l
33850.3
28127.2
0.07
12
43
(3023520) Reticulocytes [#/volume] in Blood
81
497
1.71
4.57
2.8
2.5
e9/l
63.4
68.4
0.75
59
389
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
21
4.81
4.54
2.3
2.0
u/ml
1630.8
890.0
—
10
21
(3007164) IgA [Mass/volume] in Serum or Plasma
123
840
1.56
4.53
1.4
1.4
g/l
2.7
2.6
0.33
83
502
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
78
475
1.72
4.52
2.0
1.8
%
1.7
1.6
0.89
67
405
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
210
1603
1.44
4.48
2.9
2.4
u/l
60.5
55.9
1.15
197
1481
(3016018) Differential panel - Cerebral spinal fluid
12
30
4.05
4.45
1.6
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
50
3.25
4.35
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
50
269
1.92
4.34
5.1
3.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
46
241
1.97
4.31
2.7
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
84
2.67
4.26
1.8
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
83
524
1.66
4.22
4.7
3.7
mmol/l
2.4
2.0
0.53
64
410
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
60
347
1.79
4.17
5.1
3.9
mmol/l
1.3
2.0
0.57
50
261
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
68
2.84
4.15
1.3
1.7
g/l
0.8
0.8
0.10
13
56
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
404
1.73
4.04
1.8
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
87
2.58
4.00
1.5
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
52
292
1.84
3.98
1.7
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
101
684
1.55
3.86
2.8
2.4
%
1.7
1.8
0.29
89
607
(4062490)
13
39
3.38
3.77
1.5
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
217
1.94
3.76
2.3
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
90
2.49
3.75
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
62
375
1.71
3.71
6.0
4.1
%
0.0
0.1
0.96
25
116
(3002179) Metamyelocytes/100 leukocytes in Blood
60
361
1.72
3.66
6.0
4.0
%
0.3
0.4
0.47
19
97
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
40
3.29
3.64
1.3
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
46
3.08
3.54
1.4
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
52
2.92
3.48
1.2
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
47
3.02
3.42
1.6
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
26
120
2.21
3.42
1.3
3.1
umol/l
24.2
35.2
1.73
21
97
(3044640) Blood type and Crossmatch panel - Blood
208
1651
1.36
3.41
3.9
2.5
—
—
—
0
0
(3009343) pH of Capillary blood
60
369
1.68
3.40
5.4
3.8
ph
7.4
7.4
—
6
43
(1761868) Lipid panel - Serum or Plasma
108
1484
0.68
3.38
2.9
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
222
1782
1.35
3.38
4.1
3.1
ng/l
2911.4
2054.9
1.32
200
1520
(3017181) Myelocytes/100 leukocytes in Blood
64
402
1.65
3.35
5.9
4.0
%
0.5
0.8
0.87
26
128
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
29
142
2.09
3.31
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
29
142
2.09
3.31
1.6
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
91
625
1.52
3.27
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
139
1043
1.41
3.17
2.1
1.7
mg/l
1.3
1.4
0.06
107
822
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
142
1073
1.40
3.11
5.2
4.0
ng/l
910.5
278.5
0.99
121
904
(3000492) Spirometry study
65
418
1.61
3.11
1.5
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
61
387
1.63
3.08
1.7
2.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
8
7.55
3.06
1.3
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
29
3.48
3.05
1.1
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
120
2.12
3.01
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
75
503
1.55
3.01
5.1
4.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
99
705
1.47
2.99
1.4
1.3
iu/ml
65.6
37.1
0.45
32
223
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
52
2.73
2.90
1.9
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
58
2.62
2.89
6.7
3.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
198
1596
1.33
2.87
2.4
2.1
u/l
310.1
274.1
0.17
185
1492
(3019309) Folate [Moles/volume] in Red Blood Cells
149
1150
1.37
2.87
2.0
1.8
nmol/l
1113.2
1158.2
0.25
111
856
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
123
2.07
2.84
2.0
2.0
g/l
114.5
128.2
1.23
13
93
(3021589) Normoblasts [#/volume] in Blood
255
2134
1.30
2.82
18.6
10.0
e9/l
0.0
0.0
0.96
201
1729
(3036481) Cortisol [Moles/volume] in Serum or Plasma
65
429
1.57
2.81
2.2
2.0
nmol/l
383.1
380.3
0.04
57
388
(3018418) pH of Serum or Plasma
194
1574
1.32
2.67
5.7
4.0
ph
7.4
7.4
0.64
30
298
(3044290) Cell count panel - Cerebral spinal fluid
17
73
2.36
2.67
1.4
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
15
4.70
2.60
1.7
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
19
87
2.22
2.59
1.4
1.3
mmol/l
4.3
3.9
0.35
19
80
(3001122) Ferritin [Mass/volume] in Serum or Plasma
244
2050
1.29
2.58
3.8
2.7
ug/l
199.4
158.6
0.92
226
1855
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
54
349
1.59
2.57
1.8
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
93
675
1.43
2.56
1.3
1.3
u/ml
19.2
14.1
0.19
26
263
(3013826) Glucose [Moles/volume] in Serum or Plasma
352
3095
1.27
2.56
7.2
4.8
mmol/l
6.6
6.8
0.92
334
2898
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
45
279
1.65
2.52
10.6
10.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
433
4734
0.79
2.49
5.1
5.0
mmol/l
2.5
2.6
1.32
393
4260
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
39
2.85
2.48
1.5
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
123
1.98
2.48
5.5
3.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
21
3.84
2.47
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
343
3016
1.26
2.46
5.4
3.1
u/l
59.7
52.8
0.62
320
2775
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
45
2.69
2.46
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
45
2.69
2.46
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
45
2.69
2.46
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
45
2.69
2.46
1.3
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
34
2.97
2.42
1.4
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
27
3.36
2.40
2.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
228
1915
1.28
2.39
2.6
2.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
17
4.15
2.36
2.3
4.0
%
74.4
54.1
—
7
17
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
28
3.24
2.31
2.0
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
35
2.88
2.31
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
53
2.48
2.28
1.3
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
495
5306
0.79
2.25
42.7
23.7
e9/l
251.6
239.6
2.76
488
5138
(3025159) Blasts/100 leukocytes in Blood
54
361
1.54
2.25
6.3
4.2
%
0.0
0.1
0.87
22
102
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
9
5.58
2.21
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
36
2.80
2.21
1.1
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
36
2.80
2.21
2.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
36
2.80
2.21
1.1
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
496
5311
0.79
2.20
42.7
23.8
e9/l
7.5
6.9
2.35
488
5124
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
196
0.40
2.20
1.4
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
418
4560
0.80
2.20
4.7
4.5
mmol/l
1.5
1.4
1.22
377
4110
(3026361) Erythrocytes [#/volume] in Blood
496
5309
0.79
2.18
42.6
23.7
e12/l
4.3
4.4
3.55
487
5123
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
24
3.36
2.18
4.8
4.1
nmol/l
114.2
90.4
—
8
24
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
19
3.71
2.15
1.3
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
19
3.71
2.15
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
19
3.71
2.15
1.0
1.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
30
175
1.74
2.12
1.4
3.7
mg/l
27.8
33.7
0.82
24
141
(3034860) Kappa light chains.free [Mass/volume] in Serum
30
175
1.74
2.12
1.4
3.6
mg/l
50.3
100.8
0.76
23
141
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
152
1230
1.30
2.11
3.7
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
37
2.73
2.11
2.8
2.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
424
4607
0.81
2.09
4.6
4.5
mmol/l
4.4
4.5
0.63
383
4183
(3023410) Appearance of Cerebral spinal fluid
9
31
2.93
2.07
1.8
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
110
1.94
2.07
1.5
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
10
5.03
2.07
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
50
2.42
2.03
1.2
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
196
2305
0.80
2.02
4.3
5.2
ug/l
6.5
5.3
0.11
173
2020
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
44
2.52
2.02
1.1
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
38
2.65
2.01
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
38
2.65
2.01
1.2
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
38
2.65
2.01
1.2
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
69
497
1.43
2.01
3.9
3.1
ng/l
261.3
237.4
0.16
60
450
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
70
2.17
1.99
1.1
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
295
0.50
1.97
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
127
1.84
1.96
2.6
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
165
1362
1.27
1.96
3.4
2.8
umol/l
367.8
7370.7
5.43
140
1153
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
152
1835
0.78
1.95
4.1
4.5
%
22.7
21.7
0.38
76
925
(40768443) Skin Pathology biopsy report
35
219
1.63
1.94
1.3
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
16
3.77
1.94
1.0
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
220
1.62
1.91
1.7
2.5
g/l
3.6
3.8
0.34
19
155
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
220
1.62
1.91
1.7
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
220
1.62
1.91
1.7
2.5
g/l
7.7
7.5
0.26
19
161
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
303
0.52
1.89
1.4
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
252
2191
1.23
1.88
5.1
4.0
ng/l
42.0
44.9
0.19
187
1628
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
206
1.63
1.86
1.8
2.6
g/l
3.2
3.2
0.06
19
158
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
78
583
1.38
1.86
3.2
2.6
umol/l
4.8
9.4
4.80
68
516
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.19
1.82
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
73
2.08
1.81
1.8
2.6
mg/l
28.2
23.5
—
5
18
(3015377) Calcium [Moles/volume] in Serum or Plasma
209
1788
1.24
1.81
3.4
3.4
mmol/l
2.3
2.3
0.55
173
1533
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
35
2.59
1.80
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
35
2.59
1.80
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
35
2.59
1.80
1.3
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
29
2.78
1.79
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
241
1.56
1.77
1.1
1.2
iu/ml
138.1
144.4
0.03
14
85
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
41
2.46
1.76
1.3
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
81
2.00
1.76
1.5
1.3
miu/ml
35.9
224.5
—
7
33
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
36
2.52
1.74
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
36
2.52
1.74
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
36
2.52
1.74
1.3
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
41
275
1.52
1.73
2.4
2.5
—
7.0
—
0
10
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
116
931
1.29
1.72
3.9
3.1
e6/l
1.3
1.1
0.12
73
554
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
48
2.31
1.71
2.0
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
227
1973
1.22
1.68
2.4
2.2
nmol/l
78.3
77.0
0.24
205
1726
(3018095) Leukocytes [#/volume] in Urine
221
1916
1.22
1.67
5.3
4.0
e6/l
84.9
127.9
0.38
163
1432
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
8
31
2.60
1.66
1.6
1.2
—
82.0
—
0
5
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
30
189
1.61
1.65
1.4
2.9
g/l
0.4
1.0
0.68
19
161
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
432
4637
0.83
1.65
5.0
4.8
mmol/l
5.9
6.1
1.37
387
4130
(3035320) C reactive protein [Mass/volume] in Body fluid
7
25
2.82
1.65
5.1
2.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
98
1.86
1.63
2.8
1.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
20
3.02
1.58
1.0
1.3
%
28.2
22.5
—
6
10
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
129
1.73
1.58
1.7
1.4
ug/g
330.4
277.4
0.48
15
69
(3011397) Hemoglobin [Presence] in Urine by Test strip
133
1099
1.26
1.57
4.2
3.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
106
1303
0.78
1.56
3.3
3.1
ug/l
0.8
0.8
0.36
71
891
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
85
1.90
1.56
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
411
4415
0.84
1.51
4.1
4.0
mmol/l
1.2
1.3
0.96
367
3954
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
21
2.87
1.51
15.0
14.1
nmol/l
698.7
913.5
—
6
21
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
21
2.87
1.51
28.0
19.1
nmol/l
1483.8
1516.2
—
6
21
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
28
178
1.60
1.51
1.4
2.6
g/l
36.5
36.7
0.04
17
146
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
287
2573
1.19
1.50
3.3
2.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
20
116
1.74
1.50
1.7
1.7
e6/l
8040.0
16596.5
0.94
15
89
(3037467) Urinalysis macro (dipstick) panel - Urine
378
3479
1.18
1.44
6.0
4.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
81
1.87
1.41
1.3
1.1
u/ml
355.1
279.1
—
9
41
(3035637) Corticotropin [Mass/volume] in Plasma
10
46
2.19
1.40
1.1
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
35
240
1.48
1.37
1.3
1.3
—
34.4
—
0
16
(3021788) Differential panel - Synovial fluid
15
82
1.85
1.36
1.5
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.95
1.36
2.0
2.7
%
84.4
97.3
—
5
17
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
109
896
1.25
1.35
4.0
3.3
e6/l
1.6
1.6
0.03
64
523
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
200
1.52
1.34
1.8
2.6
g/l
10.5
10.5
0.03
20
169
(3014271) Vancomycin [Susceptibility]
9
42
2.16
1.34
3.2
2.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
66
509
1.33
1.33
2.6
2.6
ug/l
6.7
6.9
0.04
50
441
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
224
1983
1.19
1.33
4.7
3.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
76
1.86
1.30
1.6
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
34
2.37
1.29
1.6
1.1
promille
1.4
1.4
—
8
25
(3000850) Epithelial cells [#/volume] in Urine
142
1209
1.22
1.28
3.4
2.6
e6/l
4.4
4.4
0.03
125
1055
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
130
1.63
1.28
1.9
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
178
1.54
1.28
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
256
2300
1.17
1.27
5.6
4.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
35
2.30
1.27
2.0
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
115
1.67
1.26
3.6
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
118
0.42
1.25
2.6
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
361
0.65
1.25
4.5
3.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
85
1.78
1.23
3.1
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
93
1.74
1.22
4.8
3.0
e9/l
4.4
4.7
0.18
16
93
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
19
2.64
1.22
1.4
1.8
ug/l
38.6
55.1
—
5
19
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
19
2.64
1.22
4.0
2.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
19
2.64
1.22
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
109
1.67
1.19
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
249
1.43
1.17
1.7
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
110
1.65
1.16
2.8
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
110
1.65
1.16
2.8
1.9
—
—
—
0
0
(3035880) pH of Pleural fluid
8
39
2.06
1.15
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
58
450
1.31
1.15
3.3
3.6
—
—
—
0
0
(3026782) Osmolality of Urine
135
1158
1.20
1.14
3.3
2.9
mosm/kgh2o
548.4
564.6
0.40
119
975
(36304419) Bacteria [Presence] in Urine
168
1471
1.18
1.13
4.6
3.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
10
51
1.97
1.11
4.4
3.3
nmol/l
7.6
6.9
—
10
51
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
96
1.68
1.11
5.7
3.6
%
59.2
60.2
0.13
16
96
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
61
481
1.29
1.08
3.4
2.4
u/l
32.9
34.7
0.18
54
399
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
280
1.38
1.06
2.2
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
132
1520
0.84
1.05
3.4
3.2
mg/l
98.5
320.2
1.48
87
997
(3044941) Cell count panel - Synovial fluid
12
67
1.80
1.05
1.2
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
47
1.93
1.02
1.6
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
42
317
1.34
1.02
2.2
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
424
4474
0.87
1.01
5.8
6.2
mmol/mol
40.6
40.7
0.06
386
4077
(40768795) Lymph node Pathology biopsy report
9
48
1.89
1.00
1.4
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
478
5002
0.87
1.00
25.1
15.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
223
1.41
1.00
1.4
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
29
400
0.71
1.00
1.6
2.3
nmol/l
13.9
12.5
0.38
24
348
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
148
1.50
0.99
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
23
2.18
0.98
1.6
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
18
116
1.57
0.97
1.0
1.2
—
58.8
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
10
54
1.86
0.97
3.9
2.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
191
1.43
0.96
3.9
3.1
g/l
0.4
0.2
0.53
11
72
(3022217) INR in Platelet poor plasma by Coagulation assay
97
822
1.21
0.94
28.0
27.4
inr
1.5
1.4
—
9
99
(3017704) Immunofixation for Urine
7
37
1.90
0.94
1.0
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
109
1.57
0.94
2.9
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
364
3412
1.13
0.94
6.2
4.8
e6/l
6216.8
3100.2
—
10
68
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
24
167
1.45
0.93
1.3
2.8
g/l
0.0
0.0
0.50
19
150
(4306422)
9
52
1.74
0.92
1.3
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
134
1.51
0.92
9.2
3.9
mmol/l
3.7
2.6
0.62
13
89
(3002582) Erythrocytes [#/volume] in Urine
189
1699
1.15
0.91
4.7
3.5
e6/l
43.5
123.9
1.29
155
1338
(3027944) Amphetamines [Presence] in Urine
17
110
1.56
0.91
2.8
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
489
5095
0.88
0.90
33.7
19.3
umol/l
87.4
84.9
0.38
489
5090
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
63
1.76
0.90
1.2
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
143
1615
0.86
0.90
4.2
4.0
mg/mmol
14.2
9.8
0.47
92
1045
(3037756) Immunofixation for Serum or Plasma
19
127
1.51
0.89
1.1
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
326
3480
0.89
0.89
5.1
4.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
42
1.91
0.88
1.5
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
30
2.01
0.87
1.7
3.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
30
2.01
0.87
1.3
2.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
30
2.01
0.87
8.0
12.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
64
1.73
0.86
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
64
1.73
0.86
1.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
64
1.73
0.86
1.2
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
173
1552
1.15
0.86
4.5
3.4
e6/l
0.6
0.5
0.10
138
1200
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
120
1.51
0.86
1.9
1.3
—
—
—
0
0
(4281824)
8
45
1.79
0.84
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
30
223
1.36
0.83
8.4
3.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
65
1.70
0.82
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
65
1.70
0.82
1.2
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
105
1.54
0.82
3.0
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
250
1.34
0.81
1.3
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
56
457
1.24
0.80
2.1
2.2
ug/g
278.1
131.9
0.88
43
363
(40761536) Microorganisms panel - Urine sediment
34
439
0.76
0.79
5.6
3.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
48
1.67
0.79
1.1
1.1
—
—
—
0
0
(4211845)
0
26
0.00
0.78
0.0
3.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
17
115
1.49
0.77
3.9
2.2
%
13.5
15.7
—
9
60
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
491
5089
0.89
0.74
18.9
10.5
u/l
24.4
25.7
1.16
482
4861
(3050129) First trimester maternal screen panel - Serum or Plasma
9
55
1.64
0.73
1.8
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
113
995
1.16
0.73
7.5
4.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
488
5057
0.89
0.72
34.0
19.3
mmol/l
139.0
139.6
5.26
483
4891
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
26
1.93
0.70
1.0
1.1
—
9.1
—
0
8
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
489
5063
0.90
0.70
34.2
19.5
mmol/l
4.0
4.0
0.18
483
4894
(3044927) Protein electrophoresis panel - Urine
11
69
1.60
0.68
1.3
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
21
153
1.38
0.67
1.3
2.9
g/l
0.0
0.0
0.00
16
139
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
136
1.41
0.67
1.7
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
48
395
1.23
0.66
4.6
4.0
ng/l
95.1
91.0
0.11
42
347
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
78
1.55
0.66
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
71
609
1.18
0.65
1.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
79
1.53
0.63
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
15
104
1.45
0.63
1.3
1.6
mu/l
774.0
282.9
0.77
15
94
(3045424) Erythrocytes [Presence] in Urine
11
71
1.56
0.62
1.5
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
63
1.60
0.62
1.7
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
21
156
1.36
0.61
1.3
2.9
g/l
0.0
0.0
0.00
16
139
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
30
1.67
0.61
2.6
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
72
622
1.17
0.61
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
74
641
1.17
0.61
9.6
8.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
300
0.76
0.61
3.3
4.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
105
1.44
0.60
1.8
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
143
1568
0.89
0.60
3.5
3.1
mmol/l
6.6
7.5
1.96
123
1294
(3035350) Ketones [Presence] in Urine by Test strip
257
2413
1.10
0.59
4.5
3.9
estimate
0.0
0.0
0.00
44
469
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
22
0.00
0.59
0.0
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
257
2414
1.10
0.59
6.0
5.4
estimate
0.0
0.0
0.00
44
466
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
129
1167
1.13
0.59
1.6
1.8
pmol/l
445.2
5981540.9
0.50
107
953
(44806420)
0
23
0.00
0.58
0.0
2.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
1.1
—
0
15
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
89
1.47
0.58
1.5
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
33
265
1.26
0.57
1.2
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
19
141
1.36
0.57
3.7
2.4
kpa
7.2
7.7
0.96
19
127
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
65
1.55
0.55
1.1
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
22
168
1.32
0.55
7.5
3.2
mmol/l
3.8
3.9
0.91
22
155
(3045142) Bone marrow Pathology biopsy report
9
62
1.46
0.53
1.1
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
119
1080
1.12
0.52
4.7
4.3
kg/l
1.0
1.0
0.08
21
164
(4268621)
6
41
1.47
0.50
2.3
2.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
127
1.35
0.50
1.4
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
383
1.19
0.48
2.7
3.1
ml/min/173m2
56.1
60.4
0.35
23
163
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
85
1.42
0.47
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
164
1.29
0.47
4.3
3.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
258
2449
1.08
0.46
4.5
4.0
estimate
0.0
0.0
0.50
45
453
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
49
1.43
0.46
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
413
4262
0.93
0.44
31.0
17.7
%
37.9
39.1
1.30
255
2822
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
127
0.71
0.43
1.3
1.8
nmol/l
55.1
43.6
—
9
120
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70
623
1.14
0.43
4.4
4.6
%
33.8
32.1
0.45
49
398
(3008898) HLA-B27 [Presence]
9
129
0.69
0.43
1.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
31
1.62
0.43
6.4
3.0
u/ml
21.4
68.2
—
5
31
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
32
1.57
0.42
1.4
1.4
%
80.4
64.5
—
5
18
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
32
1.57
0.42
1.0
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
70
1.43
0.42
3.2
1.8
%
85.0
89.8
—
10
70
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
33
1.52
0.41
8.4
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
5.8
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
15
0.00
0.41
0.0
1.2
—
7.7
—
0
15
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
150
1.27
0.40
2.9
2.7
mg/l
1.6
1.8
0.27
19
136
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
104.0
—
0
13
(3041096) Erythrocytes [Presence] in Urine by Automated
126
1354
0.92
0.38
4.4
3.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
144
1347
1.09
0.37
1.9
1.6
nmol/l
18.4
20.3
0.97
125
1136
(4094501)
8
115
0.69
0.37
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
37
1.35
0.37
2.0
1.8
%
7.8
10.7
—
5
37
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
32
272
1.18
0.36
4.2
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
70
1.29
0.36
5.2
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
427
0.86
0.36
1.6
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
117
1.29
0.35
2.5
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
113
1055
1.08
0.31
3.8
3.3
mmol/l
2.5
2.5
0.38
96
914
(3001019) Free T4 and TSH panel - Serum or Plasma
11
142
0.77
0.31
1.6
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
138
1.24
0.30
3.3
3.9
mg/l
38.7
30.9
—
7
93
(3009466) Valproate [Moles/volume] in Serum or Plasma
10
75
1.34
0.30
5.6
4.0
umol/l
358.3
342.9
—
10
64
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
65
594
1.10
0.29
4.9
3.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
158
1.21
0.28
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
76
1.32
0.28
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
230
2217
1.05
0.26
2.5
2.1
pmol/l
85.6
92.6
1.60
143
1182
(42529406) Shigella sp [Presence] in Stool by Culture
19
160
1.19
0.25
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
277
0.86
0.25
1.1
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
135
0.81
0.22
1.1
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
5.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
11
0.00
0.21
0.0
1.9
—
8.3
—
0
6
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4024509)
5
43
1.16
0.21
1.4
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
423
4304
0.96
0.21
5.0
4.4
mu/l
1.8
2.0
1.93
379
3827
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
2.3
—
0
6
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
90
1.23
0.19
1.7
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
60
1.17
0.18
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
157
1.15
0.17
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
95
905
1.06
0.17
1.3
1.2
u/ml
4.4
1.5
0.44
20
218
(3005570) Glucose [Moles/volume] in Urine
7
63
1.11
0.17
1.6
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
445
4509
0.97
0.16
26.5
15.6
ml/min/173m2
77.3
75.5
0.75
377
3737
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
111
1.17
0.16
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
55
517
1.07
0.15
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
86
0.81
0.14
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
180
0.89
0.13
3.3
5.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
85
1.18
0.12
1.9
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
126
0.87
0.11
2.2
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
5
46
1.09
0.09
1.2
1.2
—
2.0
—
0
18
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
87
1.15
0.09
3.8
3.0
—
—
—
0
0
(3013512) EKG study
163
1601
1.02
0.08
5.8
4.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
20
186
1.08
0.07
2.1
2.7
u/ml
166.8
51.3
0.47
20
178
(3030981) Hyaline casts [#/volume] in Urine by Automated count
31
326
0.95
0.07
4.1
2.8
e6/l
0.2
0.3
0.47
31
319
(3003694) ABO and Rh group [Type] in Blood
118
1204
0.98
0.07
1.4
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
94
0.85
0.06
3.3
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
138
1.09
0.06
1.7
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
141
0.92
0.05
1.5
2.5
ug/min
130.5
92.8
—
6
87
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
267
1.05
0.05
2.4
2.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
343
3452
0.99
0.04
4.3
3.6
pmol/l
15.1
14.9
0.47
306
3049
(3045414) Leukocytes [Presence] in Urine
19
200
0.95
0.04
1.8
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
132
1336
0.99
0.03
5.2
4.1
estimate
0.0
0.0
0.50
41
447
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
188
1896
0.99
0.03
4.6
4.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
44
432
1.02
0.01
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
197
0.96
0.01
1.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
164
1649
0.99
0.01
4.0
3.4
—
—
—
0
0
(4034850)
14
145
0.96
0.00
16.9
11.9
—
—
—
0
0
(1002224) Polysomnography panel
15
155
0.97
0.00
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
122
0.98
0.00
2.4
3.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
308
1.01
0.00
1.2
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
488
4876
1.00
0.00
32.2
16.6
mg/l
27.2
26.8
0.11
438
3960
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
120
1202
1.00
0.00
1.7
1.6
mmol/l
1.2
1.4
0.84
106
996
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
49
1.02
0.00
1.4
2.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
91
0.99
0.00
1.2
1.9
pmol/l
202.6
225.8
—
9
83
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
53
0.94
0.00
1.0
2.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
27.3
—
0
6
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
10.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.6
—
6.2
—
0
9
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
76
0.92
0.00
1.6
1.7
pg
34.1
33.0
—
7
76
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
56
0.89
0.00
1.6
3.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
93
0.97
0.00
1.6
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
59
0.85
0.00
1.0
1.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_RESP_TUBERCU_CONF and mortality.

Females

Parameter HR [95% CI] p-value
AB1_RESP_TUBERCU_CONF 2.229 [1.96, 2.54] < 0.001
Birth year 0.992 [0.98, 1.0] 0.076

During the follow-up period (1.1.1998 — 31.12.2019), 994 out of 2033 females with AB1_RESP_TUBERCU_CONF died.

Males

Parameter HR [95% CI] p-value
AB1_RESP_TUBERCU_CONF 2.551 [2.23, 2.92] < 0.001
Birth year 0.985 [0.98, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1865 out of 3273 males with AB1_RESP_TUBERCU_CONF died.

Mortality risk

Mortality risk for people of age

years, who have AB1_RESP_TUBERCU_CONF.

N-year risk Females Males
1 0.13% 0.496%
5 0.995% 2.92%
10 2.597% 6.619%
15 5.126% 11.95%
20 9.257% 20.013%

Relationships between endpoints

Index endpoint: AB1_RESP_TUBERCU_CONF – Respiratory tuberculosis, confirmed

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data